We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$5.4B
AUM Growth
+$262M
Cap. Flow
-$15.9M
Cap. Flow %
-0.29%
Top 10 Hldgs %
47.35%
Holding
199
New
22
Increased
52
Reduced
70
Closed
9

Top Buys

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$43.2M
2
FERG icon
Ferguson
FERG
+$11.5M
3
SDHC icon
Smith Douglas Homes
SDHC
+$8.54M
4
MTDR icon
Matador Resources
MTDR
+$5.05M
5
ROP icon
Roper Technologies
ROP
+$3.11M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$35.3M
2
APO icon
Apollo Global Management
APO
+$18.4M
3
RDNT icon
RadNet
RDNT
+$9.55M
4
SHW icon
Sherwin-Williams
SHW
+$8.93M
5
ESGR
Enstar Group
ESGR
+$8.67M

Sector Composition

Rank Sector Weight
1 Financials 43.35%
2 Healthcare 13.58%
3 Technology 11.42%
4 Industrials 7.55%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
101
NVIDIA
NVDA
$4.6T
$1.01M 0.02%
7,536
+212
+3% +$29.2K
TMO icon
102
Thermo Fisher Scientific
TMO
$214B
$1.01M 0.02%
1,945
+604
+45% +$332K
FAST icon
103
Fastenal
FAST
$54.8B
$1.01M 0.02%
28,000
– –
PNC icon
104
PNC Financial Services
PNC
$99.1B
$1M 0.02%
5,200
-800
-13% -$157K
TSM icon
105
TSMC
TSM
$1.94T
$973K 0.02%
4,927
-8
-0.2% -$1.55K
D icon
106
Dominion Energy
D
$62B
$948K 0.02%
17,593
-1,372
-7% -$78.3K
CVS icon
107
CVS Health
CVS
$135B
$917K 0.02%
20,425
+232
+1% +$13K
CBSH icon
108
Commerce Bancshares
CBSH
$8.68B
$891K 0.02%
15,012
-2
-0% -$121
SHEL icon
109
Shell
SHEL
$244B
$881K 0.02%
14,057
-600
-4% -$39.3K
TSLA icon
110
Tesla
TSLA
$1.18T
$872K 0.02%
2,160
-10
-0.5% -$3.22K
IDXX icon
111
Idexx Laboratories
IDXX
$44.9B
$865K 0.02%
2,092
+77
+4% +$33.8K
BAX icon
112
Baxter International
BAX
$12.8B
$830K 0.02%
28,473
-8,867
-24% -$299K
CNI icon
113
Canadian National Railway
CNI
$78.5B
$789K 0.01%
7,775
– –
TOST icon
114
Toast
TOST
$18.9B
$763K 0.01%
20,920
-42
-0.2% -$1.48K
JPM.PRC icon
115
JPMorgan Chase & Co 6.00% Series EE Preferred Stock
JPM.PRC
$1.86B
$678K 0.01%
26,637
-4,775
-15% -$121K
MO icon
116
Altria Group
MO
$125B
$674K 0.01%
12,890
+8,925
+225% +$475K
ORCL icon
117
Oracle
ORCL
$339B
$669K 0.01%
+4,017
New +$714K
TSCO icon
118
Tractor Supply
TSCO
$16.3B
$667K 0.01%
12,574
-1
-0% -$56
GEV icon
119
GE Vernova
GEV
$240B
$630K 0.01%
1,915
– –
CARR icon
120
Carrier Global
CARR
$49.8B
$623K 0.01%
9,124
+174
+2% +$13.1K
CMCSA icon
121
Comcast
CMCSA
$87.3B
$583K 0.01%
15,539
+300
+2% +$12.5K
PAYX icon
122
Paychex
PAYX
$43.4B
$561K 0.01%
4,000
– –
ACN icon
123
Accenture
ACN
$106B
$516K 0.01%
1,466
+40
+3% +$14.4K
USB icon
124
US Bancorp
USB
$97.9B
$462K 0.01%
9,653
-137
-1% -$6.74K
DFS
125
DELISTED
Discover Financial Services
DFS
$433K 0.01%
2,500
-40
-2% -$6.57K
3 4
5
6 7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2024 Portfolio in Review

As of Q4 2024, Beck Mack & Oliver held 199 positions worth $5.4B, up 5.1% from $5.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver's Q4 2024 filing shows 22 new, 52 increased, 70 reduced and 9 closed positions. Its largest new stake was Oracle: 4,017 shares worth $669K. The largest sale was Enterprise Products Partners, an estimated $35.3M.

By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q4 2024 buy was Oracle: 4,017 shares worth $669K.
  • Beck Mack & Oliver added most to CoStar Group in Q4 2024, an estimated $43.2M increase.
  • Beck Mack & Oliver's biggest Q4 2024 reduction was Enterprise Products Partners, cutting an estimated $35.3M.
  • Beck Mack & Oliver fully exited Boston Scientific in Q4 2024, selling an estimated $421K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $5.4B portfolio in Q4 2024.
  • Beck Mack & Oliver opened 22 new positions and closed 9 in Q4 2024.
  • Beck Mack & Oliver's portfolio value rose 5.1% quarter-over-quarter to $5.4B.

Based on Beck Mack & Oliver's 13F filing for Q4 2024, filed 13 Feb 2025.